RICHARD D PETERSON
CIK 1430423 · Chief Financial Officer · last filed 2025-12-31
RICHARD D PETERSON is a Chief Financial Officer who has filed 44 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing shows the insider sold $62.3K of UVE on Dec 31, 2025. Across all open-market trades the lifetime net is −$2.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.51M
4
44
-$2.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UVE | Director | 27,455 | $37.95 | $1.04M | -$52.3K | 11 | 2025-12-31 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Chief Financial Officer | 55,800 | $0.01 | $759 | $0 | 1 | 2021-12-14 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Chief Financial Officer | 7,000 | — | — | $105.0K | 2 | 2017-08-01 |
| MRX | EVP, CFO & Corp Treasurer | 217,289 | $61.96 | $13.46M | -$2.73M | 29 | 2012-08-17 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-31 | UVE | Sell (S) | −1,855 | -$62.3K | EDGAR |
| 2025-07-30 | UVE | Grant (A) | +2,824 | $0 | EDGAR |
| 2025-06-13 | UVE | Grant (A) | +2,404 | $0 | EDGAR |
| 2024-06-17 | UVE | Grant (A) | +3,491 | $65.0K | EDGAR |
| 2023-06-22 | UVE | Grant (A) | +4,005 | $0 | EDGAR |
| 2022-10-03 | UVE | Buy (P) | +1,075 | $10.0K | EDGAR |
| 2022-06-14 | UVE | Grant (A) | +5,337 | $0 | EDGAR |
| 2021-12-14 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +55,800 | $0 | EDGAR |
| 2019-12-11 | UVE | Mixed | +9,109 | -$5 | EDGAR |
| 2019-03-18 | UVE | Grant (A) | — | $0 | EDGAR |